Open AccessDifferential Impact of Prognostically Significant Gene Mutations in Acute Myeloid Leukemia (AML) Patients (Pts) Older Than 70 Years (y) Treated with Cytarabine-Based Induction Therapy
Author(s) -
Marius Bill,
Jessica Kohlschmidt,
Krzysztof Mrózek,
Deedra Nicolet,
Christopher J. Walker,
Dimitrios Papaioannou,
James S. Blachly,
Shelley Orwick,
Eunice S. Wang,
Jonathan E. Kolitz,
Bayard L. Powell,
Andrew J. Carroll,
Ramiro Garzon,
Richard M. Stone,
John C. Byrd,
Clara D. Bloomfield,
AnnKathrin Eisfeld
Publication year - 2020
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood-2020-141663
Subject(s) - cebpa , medicine , npm1 , cytarabine , oncology , myeloid leukemia , leukemia , biology , mutation , gene , genetics , chromosome , karyotype
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom